Freezing lung biopsies: a safer way to diagnose?
NCT ID NCT07301697
First seen Jan 04, 2026 · Last updated Jun 20, 2026 · Updated 27 times
Summary
This study is testing a newer technique called cryobiopsy, which uses a freezing probe to take tissue samples from the lungs. The goal is to see how safe and accurate it is for diagnosing conditions like lung disease, tumors, or infections. Researchers at a French hospital will study 30 patients who need this procedure, comparing results to standard methods. If it works well, it could offer a less invasive option for getting a clear diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDIASTINAL LYMPHADENOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pulmonology Department - NHC Strasbourg
RECRUITINGStrasbourg, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cryobiopsy (a procedure using a freezing probe to take tissue samples)
What this could lead to
If successful, this study could help establish cryobiopsy as a standard, safer diagnostic tool for lung conditions, potentially replacing more invasive methods.
What could go wrong
This is a small, single-center study with only 30 participants, so results may not apply broadly. The procedure carries risks like bleeding or infection, and it may not outperform existing techniques.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.